Rapamycin (Sirolimus) in South Asian Patients: Documented Efficacy Gaps and Dosing Considerations
Evidence-based review of how rapamycin (sirolimus) performs differently in South Asian populations, covering pharmacogenomics, CYP3A5 polymorphisms, metabolic context, and dosing adjustments.
Read clinical review